The relationship between Menopause and Skin Changes

20 Mar

Written By Joey .

The relationship between menopause and skin changes is one of the most clinically significant — and most under-discussed — aspects of the menopausal transition. Skin is one of the largest oestrogen-responsive organs in the body, and when 17β-oestradiol levels fall to near zero after menopause, the consequences are felt in almost every structural and functional component of the dermis.^1,2 Yet in clinical practice, skin changes are frequently dismissed as a purely cosmetic concern — a framing that fails to capture how profoundly skin health influences quality of life, wound healing, immune function, and psychological wellbeing in postmenopausal women.

◆ Quick Answer

How does menopause affect the skin? Menopause causes a dramatic decline in oestrogen, which directly impacts skin structure through multiple pathways: collagen loss (up to 30% in the first five years post-menopause), reduced hyaluronic acid and glycosaminoglycan production, decreased elastin, impaired wound healing, reduced sebum production, and altered vascularity. The result is thinner, drier, less elastic skin with increased wrinkling and compromised barrier function — changes that correlate more strongly with oestrogen deficiency than with chronological ageing alone.^1,3,4

Why Oestrogen Matters So Much for Skin

Oestrogen receptors — both ERα and ERβ — are expressed throughout the skin in epidermal keratinocytes, dermal fibroblasts, melanocytes, sebaceous glands, and hair follicles.^2,5 ERβ is the more widely distributed subtype in skin, particularly in the scalp and facial skin, and its activation is now understood to be a key driver of wound healing, independent of oestrogen's anti-inflammatory effects.⁵

During the reproductive years, oestrogen drives the synthesis of procollagen I and III, tropoelastin, fibrillin, and hydrophilic glycosaminoglycans — the structural matrix that gives skin its thickness, elasticity, and moisture-holding capacity.^2,3 It also stimulates hyaluronic acid production, inhibits matrix metalloproteinases (the enzymes that break down collagen), and acts as a direct antioxidant against reactive oxygen species via the NRf2 pathway.⁵ Skin collagen and elastin typically peak around age 30, corresponding to peak oestrogen production.⁵

Menopause and Skin Changes: What the Research Shows

Collagen Loss: The Most Documented Change

The evidence on collagen loss following menopause is extensive and consistent. The landmark work of Brincat et al. demonstrated that skin collagen content declines at approximately 2.1% per postmenopausal year over a 15-year period — and critically, this decline correlates with menopausal age rather than chronological age, confirming that oestrogen deficiency rather than time itself is the primary driver.^3,7

30% of dermal collagen may be lost in the first five years following menopause — with collagen content continuing to decline at ~2.1% per year for up to 15 years post-menopause.^3,7

Both type I collagen (tensile strength) and type III collagen (flexibility) are reduced. This loss translates clinically into skin thinning, reduced structural integrity, and decreased resistance to mechanical damage.^1,3 The parallel between skin collagen loss and bone mineral density reduction post-menopause is well-documented — both reflect the same oestrogen-dependent structural maintenance mechanism.³

Elastin, Glycosaminoglycans, and Hydration

Oestrogen stimulates the production of glycosaminoglycans (GAGs) and hyaluronic acid (HA) in the dermis — potent humectants that hold large multiples of their weight in water.^2,5 The loss of these hydrophilic molecules following menopause directly reduces the skin's water-holding capacity and turgor. Raine-Fenning et al. describe a simple bedside assessment: gently pinch the skin on the back of the hand, pull upward, and observe how quickly it reconstitutes — in postmenopausal women without oestrogen replacement, this may take three to four times longer than in premenopausal women.¹

Sebum, Barrier Function, and Sensitivity

Oestrogen influences sebaceous gland function, and its decline leads to reduced sebum production — contributing to the characteristic dryness and increased skin sensitivity that many women first notice in perimenopause.^1,2 Barrier function is further compromised by reduced ceramide synthesis and impaired keratinocyte differentiation. Skin thickness shows fluctuation across the menstrual cycle — lowest when oestrogen is lowest — illustrating just how dynamically responsive skin is to oestrogen levels even before menopause.⁴

Vascularity, Wound Healing, and Immune Function

Oestrogen maintains cutaneous microvascular integrity, and capillary blood flow velocity decreases significantly in postmenopausal women, impairing nutrient delivery and immune surveillance.¹ Wound healing is meaningfully impaired — studies show delayed re-epithelialisation and reduced collagen deposition in postmenopausal women, improving upon oestrogen administration.^4,5 Oestrogen increases TGF-β1 secretion, promotes dermal fibroblast migration, and upregulates the ezrin structural protein that maintains epidermal cell-to-cell bridge integrity.⁵

Hair, Pigmentation, and Inflammatory Skin Conditions

Oestrogen modulates hair follicle cycling through ERβ pathways, and its decline is associated with increased hair loss, reduced growth rate, and shifts in hair texture.⁴ Pigmentary changes also occur, including uneven skin tone and solar lentigines driven by the combined effects of declining oestrogen and cumulative UV exposure.⁵

The perimenopause and postmenopause also influence the trajectory of existing inflammatory skin conditions. Rosacea, psoriasis, eczema, and seborrheic dermatitis may all be affected by the hormonal milieu. In my practice, I see women who have managed their skin conditions relatively well for years begin to experience worsening flares as they enter perimenopause, frequently without connecting the hormonal change to the skin deterioration.⁶

Hormone Replacement Therapy and Skin: What Does the Evidence Say?

📄 Raine-Fenning, Brincat & Muscat-Baron, Am J Clin Dermatol (2003)

This comprehensive review confirmed that oestrogen receptors on dermal cellular components mean that dermal cellular metabolism is directly influenced by the hypo-oestrogenic state of menopause. Collagen content, glycosaminoglycan concentration, and skin water content all decline in measurable ways. Both topical and systemic oestrogen appear able to reverse these changes, though the quality of evidence varies across studies.¹

📄 Lephart & Naftolin, Dermatology and Therapy (2020)

This open-access review established that skin collagen and elastin peak around age 30 — when oestrogen production peaks. After menopause, 17β-oestradiol falls to near zero, producing loss of collagen, elastin, fibroblast function, vascularity, and increased MMP activity. The review also highlighted oestrogen's antioxidant role via NRf2 pathway activation.⁵

📄 Stevenson & Thornton, Clin Interv Aging (2007)

A key review confirming that skin ageing can be significantly delayed by oestrogen administration. Skin thickness decreases by 1.13% per postmenopausal year, with collagen declining at 2% per year. A randomised, double-blind, placebo-controlled trial (Maheux et al.) demonstrated a 30% increase in dermal thickness after 12 months of oral oestrogen therapy.⁴

The KEEPS trial (Kronos Early Estrogen Prevention Study) — the only large prospective RCT of HRT effects on skin wrinkles and rigidity — found that race was the strongest predictor of skin ageing in the four years following menopause, and that MHT did not significantly affect wrinkle or rigidity scores at most facial locations.⁵ The authors noted the study may have been underpowered, and that early HRT initiation may be most beneficial for skin.

A note on HRT safety: Historical concern about HRT and cardiovascular risk arose from the Women's Health Initiative (WHI) trial, which enrolled women more than 10 years postmenopausal with pre-existing cardiovascular risk factors. Contemporary evidence supports that MHT commenced in healthy women within 6–10 years of menopause does not carry excess cardiovascular risk. HRT decisions are highly individual and should be made in partnership with your medical practitioner.⁵

Beyond HRT: Cosmeceutical and Non-Hormonal Options for Menopause Skin Changes

Selective Oestrogen Receptor Modulators (SERMs) and Phytoestrogens

ERβ is the dominant oestrogen receptor subtype in skin, and its activation drives collagen synthesis, wound healing, and barrier repair without the ERα-mediated risks associated with reproductive cancers.⁵ Two compounds reviewed by Lephart & Naftolin (2020) show particular promise: equol (an isoflavonoid produced from soy metabolite daidzein) and 4′-acetoxy resveratrol (an analogue of resveratrol). Both have in vitro and clinical evidence supporting improvement in collagen synthesis, antioxidant defence, and skin elasticity in oestrogen-deficient skin via ERβ agonism without systemic oestrogenic risks.⁵

Retinoids, Antioxidants, and Barrier Repair

Topical retinoids remain among the best-evidenced topical interventions for postmenopausal skin, working via RAR/RXR nuclear receptors to stimulate procollagen synthesis and inhibit MMP activity — mechanisms that partially overlap with oestrogen's dermal actions. Given oestrogen's antioxidant role via NRf2 activation, its loss increases skin vulnerability to oxidative stress; topical L-ascorbic acid (vitamin C), niacinamide, and resveratrol provide exogenous ROS protection.

For collagen support

Topical retinoids (tretinoin/retinol), phytoestrogen cosmeceuticals (equol, resveratrol), topical vitamin C

For hydration & barrier

Hyaluronic acid serums, ceramide-rich moisturisers, glycerol/xylitol formulations, avoiding harsh surfactants

For oxidative protection

Antioxidant serums (vitamin C, niacinamide, resveratrol), broad-spectrum SPF daily

For pigmentation & tone

Azelaic acid, niacinamide, vitamin C, targeted laser/IPL, consistent SPF

Does Menopause Cause Dry Skin?

Yes — dry skin is one of the earliest and most consistent skin changes associated with menopause, driven directly by oestrogen deficiency. Oestrogen stimulates sebaceous gland activity, glycosaminoglycan synthesis, and hyaluronic acid production — all of which contribute to skin moisture. Its decline reduces all three simultaneously. Many women first notice increased skin dryness during perimenopause, often months before other menopausal symptoms appear, and the dryness typically progresses through the postmenopausal years without intervention.^1,2,5

Does Menopause Cause Skin to Age Faster?

Yes — the evidence is consistent that oestrogen deficiency accelerates skin ageing beyond what would be expected from chronological ageing alone. The rate of extracellular matrix deterioration in postmenopausal women correlates more convincingly with oestrogen deficiency than with chronological age.^3,4 Women often notice a sudden acceleration of skin ageing several months after menopausal symptoms begin — reflecting the sharp drop in oestrogen rather than the gradual attrition of time.^1,4,5

A Clinical Perspective: What I Focus On in Practice

When I see patients presenting with skin changes around perimenopause or post-menopause, my approach is integrative rather than purely topical. The first conversation is always about where they are hormonally — a comprehensive review of their oestrogen, progesterone, testosterone, and thyroid status, along with nutritional markers (particularly vitamin D, which I find deficient in a very high proportion of perimenopausal women) and inflammatory markers.

What I find most important is that women are not dismissed about their skin symptoms. A survey finding that 100% of menopausal women have skin symptoms, yet nearly half don't mention them to their doctor, represents a significant clinical gap. These changes are real, biologically well-explained, and treatable.

Frequently Asked Questions: Menopause and Skin Changes

What are the most common skin changes during menopause?

The most common changes include increased dryness, skin thinning, loss of firmness and elasticity, increased wrinkling, uneven pigmentation, impaired wound healing, increased skin sensitivity, and changes to facial hair patterns. These reflect the multiple roles oestrogen plays in maintaining collagen, hyaluronic acid, elastin, sebum production, and vascular integrity in the skin.^1,2,5

When do menopause-related skin changes begin?

Many women first notice skin changes during perimenopause — often before formal menopause is confirmed — as oestrogen levels begin to fluctuate. The most rapid structural changes (particularly collagen loss) occur in the first five years after the final menstrual period, after which the decline continues at a slower but cumulative rate for at least 15 years.^3,4,7

Can HRT reverse menopause skin changes?

HRT can significantly attenuate and partially reverse menopause-related skin changes, particularly when started early in the postmenopausal period. Studies have shown increases in skin thickness, collagen content, hydration, and elasticity with oestrogen therapy — both topical and systemic.^1,4 Topical oestrogen may have more concentrated local effects than systemic treatment.⁵

What can I use on my skin during menopause if I don't want HRT?

Several evidence-informed topical options can help address menopause skin changes without systemic hormones. Topical retinoids (retinol or prescription tretinoin) stimulate collagen synthesis. Phytoestrogen cosmeceuticals targeting ERβ (equol and resveratrol analogues) may provide some oestrogenic skin signalling. Hyaluronic acid and ceramide-rich formulations address hydration and barrier repair. Topical vitamin C and antioxidants counter the increased oxidative stress from reduced endogenous oestrogen. Daily broad-spectrum SPF remains fundamental.^4,5

Why do inflammatory skin conditions worsen at menopause?

Oestrogen has significant anti-inflammatory and immune-modulatory roles in skin — it influences Langerhans cells, mast cells, and keratinocyte immune responses. Its decline at menopause disrupts these regulatory mechanisms, potentially lowering the threshold for inflammatory flaring in conditions like rosacea, eczema, and seborrheic dermatitis. Reduced barrier function simultaneously increases skin reactivity to triggers.^5,6

Conclusion: Understanding Menopause and Skin Changes Is Clinical, Not Cosmetic

The skin changes of menopause reflect the loss of a hormone that plays a fundamental role in skin structural integrity, immune function, barrier competence, and wound healing. Understanding menopause and skin changes through this lens changes the clinical conversation — from "here's a moisturiser" to a genuine investigation of hormonal status, nutritional deficiencies, and targeted interventions based on the individual's profile and preferences.

Experiencing skin changes around perimenopause or menopause?

Book a functional skin and hormonal consultation. Together we'll look at the full picture — not just what's on the surface — and build a plan that addresses the root causes.

References

Raine-Fenning NJ, Brincat MP, Muscat-Baron Y. Skin aging and menopause: implications for treatment. Am J Clin Dermatol. 2003;4(6):371–378.
Brincat MP. Hormone replacement therapy and the skin. Maturitas. 2000;35(2):107–117.
Brincat M, Moniz CJ, Studd JW, et al. Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol. 1985;92(3):256–259.
Stevenson S, Thornton J. Effect of estrogens on skin aging and the potential role of SERMs. Clin Interv Aging. 2007;2(3):283–297.
Lephart ED, Naftolin F. Menopause and the skin: old favorites and new innovations in cosmeceuticals for estrogen-deficient skin. Dermatol Ther (Heidelb). 2021;11(1):53–69.
Kamp E, et al. Menopause, skin and common dermatoses. Clin Exp Dermatol. 2022;47(12):2117–2122.
Rzepecki AK, et al. Estrogen-deficient skin: the role of topical therapy. Int J Womens Dermatol. 2019;5(2):85–90.
Thornton MJ. Estrogens and aging skin. Dermatoendocrinol. 2013;5(2):264–270.
Hall G, Phillips TJ. Estrogen and skin: the effects of estrogen, menopause, and hormone replacement therapy on the skin. J Am Acad Dermatol. 2005;53(4):555–568.
Affinito P, et al. Effects of postmenopausal hypoestrogenism on skin collagen. Maturitas. 1999;33(3):239–247.
Maheux R, et al. A randomized, double-blind, placebo-controlled study on the effect of conjugated estrogens on skin thickness. Am J Obstet Gynecol. 1994;170(2):642–649.
Ashcroft GS, et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels. Nat Med. 1997;3(11):1209–1215.
Owen CM, et al. Effects of hormones on skin wrinkles and rigidity vary by race/ethnicity: KEEPS ancillary skin study. Fertil Steril. 2016;106(5):1170–1175.

Joey .